Jon Lerner
Partner @ Smedvig Ventures
London, United Kingdom
Jon Lerner is a Managing Director at Smedvig Capital, which he joined in 2008 from Bain & Company. Prior to Smedvig Capital Jon worked at Bain and Company as a Senior Consultant supporting FTSE 100 management teams in the oil and gas, petrochemicals, financial services and consumer products sectors. Jon has also spent 6 months working in houseat Argos on multi channel strategy and product expansion.Jon splits his time between finding fast growing businesses in the UK / Nordics and closely supporting two of our portfolio companies, Mediamorph and Tusker, and was previously an advisor to Selstor.Jon has a first class MEng in Electrical and Electronic Engineering with French from Bristol University.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Jon Lerner invests in
Stages Jon Lerner invests in
Countries Jon Lerner invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Content 1 (13%)
- Medical 1 (13%)
- Payments 1 (13%)
- Software 1 (13%)
- E-Commerce 1 (13%)
Stage
- Series A 3 (38%)
- Series B 3 (38%)
- Series C 1 (13%)
Country
- United Kingdom 2 (25%)
- United States 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Semble is a healthcare technology company that develops practice management and electronic health record software for private healthcare providers. The company offers an integrated platform that combines patient records, appointment scheduling, telehealth, billing, payments, clinical documentation, prescribing, and care coordination tools within asingle system. Its software is designed to support the delivery and administration of healthcare services across clinics, medical practices, and multi-site healthcare organizations. The platform enables healthcare professionals to manage patient journeys from initial booking through consultation, treatment, follow-up care, and payment processing. It includes electronic health record functionality, clinical note management, patient communication tools, online booking capabilities, and workflow automation features that help streamline administrative and clinical processes.In addition to clinical and administrative functions, the company offers analytics, reporting, patient engagement, and automation tools that help healthcare organizations manage operations and monitor performance. Its solutions are used by a range of healthcare providers, including physicians, specialists, mental health professionals, physiotherapists, pharmacies, and occupational health organizations. | $15M / Series B / Oct 23, 2024 | ||
| Semble is a healthcare technology company that develops practice management and electronic health record software for private healthcare providers. The company offers an integrated platform that combines patient records, appointment scheduling, telehealth, billing, payments, clinical documentation, prescribing, and care coordination tools within asingle system. Its software is designed to support the delivery and administration of healthcare services across clinics, medical practices, and multi-site healthcare organizations. The platform enables healthcare professionals to manage patient journeys from initial booking through consultation, treatment, follow-up care, and payment processing. It includes electronic health record functionality, clinical note management, patient communication tools, online booking capabilities, and workflow automation features that help streamline administrative and clinical processes.In addition to clinical and administrative functions, the company offers analytics, reporting, patient engagement, and automation tools that help healthcare organizations manage operations and monitor performance. Its solutions are used by a range of healthcare providers, including physicians, specialists, mental health professionals, physiotherapists, pharmacies, and occupational health organizations. | $8.3M / Series A / Sep 28, 2021 | ||
| Quill has merged with Jellyfish to become their global Ecommerce Content capability, delivering multi-language content solutions that support Jellyfish’s cutting-edge digital transformation services | $4.6M / Series B / Jul 14, 2017 | ||
| Mediamorph’s mission is to boost business performance and accelerate content value across the entertainment ecosystem. The company's platform provides actionable insights into financial, rights and consumption information, enabling content providers to stay connected to the rapidly growing ecosystem and complex world of video distribution. | $21.1M / Series C / Aug 22, 2016 | ||
| Mediamorph’s mission is to boost business performance and accelerate content value across the entertainment ecosystem. The company's platform provides actionable insights into financial, rights and consumption information, enabling content providers to stay connected to the rapidly growing ecosystem and complex world of video distribution. | $13M / Series B / Sep 11, 2014 | ||
| Quill has merged with Jellyfish to become their global Ecommerce Content capability, delivering multi-language content solutions that support Jellyfish’s cutting-edge digital transformation services | $6.5M / Series A / Mar 10, 2014 | ||
| Mediamorph’s mission is to boost business performance and accelerate content value across the entertainment ecosystem. The company's platform provides actionable insights into financial, rights and consumption information, enabling content providers to stay connected to the rapidly growing ecosystem and complex world of video distribution. | $2.5M / Series A / Mar 01, 2013 | ||
| Mediamorph’s mission is to boost business performance and accelerate content value across the entertainment ecosystem. The company's platform provides actionable insights into financial, rights and consumption information, enabling content providers to stay connected to the rapidly growing ecosystem and complex world of video distribution. | $2M / Series A / Jun 28, 2012 |
Co-Investors
About Smedvig Ventures
Smedvig Ventures helps B2B tech teams scale more confidently. We invest between €4-8m in rounds of up to €20m across Europe. We support our select portfolio of ambitious teams from early traction to inspiring success stories focusing on taking founder led businesses to strong leadership teams and from product market fit to go-to market fit onwards.We’ve made this journey countless times over more than two decades and provide focused input that creates the biggest impact. The Smedvig family have been passionate about innovation for over 100 years. Put simply, having their complete backing means we can give you ours.
Smedvig Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Cristian Young
CFO
|
|||
|
Jon Lerner
Partner
|
|||
Rob Toms
Managing Director
|
|||
Alistair Cairns
Managing Director
|
|||
Freddie Kalfayan
Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jon Lerner invest in?
Jon Lerner invests primarily in Content, Medical and Payments startups, most often at Series A and Series B stage. Most of the 8 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jon Lerner?
Public channels for Jon Lerner include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jon Lerner last invest?
The most recent investment recorded for Jon Lerner closed in Oct 2024. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
